Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Stoke Therapeutics, Inc:
We consent to the use of our report dated March 23, 2020 incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP |
Boston, Massachusetts |
July 10, 2020 |
